Evaluation of FDY-5301 in Major Trauma Patients in ICU

Stopped The study was terminated because of difficulty identifying patients that met the inclusion criteria, as well as logistical difficulties in opening clinical ICU study sites.

Conditions

• ICU Acquired Weakness

Interventions

• DRUG: FDY-5301
• OTHER: Placebo

Sponsor

Faraday Pharmaceuticals, Inc.